Dr. Ellison is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2085 Henry Tecklenburg Dr
Second floor
Charleston, SC 29414Phone+1 843-577-6957Fax+1 843-577-6523
Education & Training
Duke University HospitalFellowship, Hematology and Medical Oncology, 1987 - 1990
Johns Hopkins UniversityResidency, Internal Medicine, 1984 - 1987
Duke University School of MedicineClass of 1984
Certifications & Licensure
SC State Medical License 1990 - 2025
NC State Medical License 1987 - 1992- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Study of Glembatumumab Vedotin (CDX-011) in Patients With Metastatic, gpNMB Over-Expressing, Triple Negative Breast Cancer Start of enrollment: 2013 Nov 01
- A Study of AL101 Monotherapy in Patients With Notch Activated Triple Negative Breast Cancer Start of enrollment: 2020 Aug 14
Publications & Presentations
PubMed
- 5 citationsNRG Oncology/NSABP B-47 menstrual history study: impact of adjuvant chemotherapy with and without trastuzumab.Patricia A. Ganz, Reena S. Cecchini, Louis Fehrenbacher, Charles E. Geyer, Priya Rastogi
NPJ Breast Cancer. 2021-05-20 - 34 citationsAn open-label, phase II study of the polo-like kinase-1 (Plk-1) inhibitor, BI 2536, in patients with relapsed small cell lung cancer (SCLC).Mark M. Awad, Quincy Chu, Leena Gandhi, Joe Stephenson, Ramaswamy Govindan
Lung Cancer. 2017-02-01
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
